These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17136996)

  • 1. Severe, early-onset emphysema with normal alphal-antitrypsin levels in nonsmokers: a clinical dilemma.
    Kim V; Kueppers F; D'Alonzo GE
    COPD; 2004; 1(2):313-9. PubMed ID: 17136996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities in the Computed Tomography Appearance in α1-Antitrypsin Deficiency and Smoking-Related Chronic Obstructive Pulmonary Disease in a Smoking Collective.
    Konietzke P; Jobst B; Wagner WL; Jarosch I; Graber R; Kenn K; Kauczor HU; Wielpütz MO
    Respiration; 2018; 96(3):231-239. PubMed ID: 29940576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower-zone emphysema in young patients without alpha1-antitrypsin deficiency.
    Martelli NA; Goldman E; Roncoroni AJ
    Thorax; 1974 Mar; 29(2):237-44. PubMed ID: 4545502
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
    Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
    COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homozygous inherited alpha1-antitrypsin deficiency with emphysema of the lung, cor pulmonale, and gout (author's transl)].
    Fruhmann G; Fritz H; Bergstermann H
    Klin Wochenschr; 1974 Jan; 52(2):80-9. PubMed ID: 4206093
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of regional progression of pulmonary emphysema with CT densitometry.
    Bakker ME; Putter H; Stolk J; Shaker SB; Piitulainen E; Russi EW; Stoel BC
    Chest; 2008 Nov; 134(5):931-937. PubMed ID: 18625668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual case of rapid radiological progression of bullous emphysema secondary to severe α1-antitrypsin deficiency.
    Chew JR; Roy K; Babar J; Mahadeva R
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25953582
    [No Abstract]   [Full Text] [Related]  

  • 9. Emphysema and bronchiectasis secondary to alpha-1 antitrypsin deficiency.
    Fahim A; Wilmot R; Hart SP
    J Coll Physicians Surg Pak; 2013 Mar; 23(3):224-5. PubMed ID: 23458051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary emphysema and alpha1-antitrypsin deficiency.
    Jones SH
    Phys Ther; 1974 Jun; 54(6):579-83. PubMed ID: 4214194
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary emphysema in a nonsmoker with normal alpha-1-antitrypsin.
    Habenstein KR; Roy TM; Fields CL
    J Ky Med Assoc; 1992 Jul; 90(7):327-30. PubMed ID: 1500832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1 antitrypsin levels in chronic obstructive lung disease and pulmonary tuberculosis in Singapore.
    Poh SC; Seet AM
    Singapore Med J; 1975 Jun; 16(2):89-91. PubMed ID: 1080579
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early pulmonary emphysema and alpha 1 antitrypsine deficiency. Study on 222 cases with respiratory insufficiency].
    Haas C
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):673-6. PubMed ID: 4212628
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of HIV infection on α
    Stephenson SE; Wilson CL; Crothers K; Attia EF; Wongtrakool C; Petrache I; Schnapp LM
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L583-L592. PubMed ID: 29351445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary
    Lessard E; Young HM; Bhalla A; Pike D; Sheikh K; McCormack DG; Ouriadov A; Parraga G
    Acad Radiol; 2017 Nov; 24(11):1402-1411. PubMed ID: 28645458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT of emphysema.
    Newell JD
    Radiol Clin North Am; 2002 Jan; 40(1):31-42, vii. PubMed ID: 11813818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1-antitrypsin deficiency and emphysema.
    George RB; Richardson JV
    J La State Med Soc; 1973 Sep; 125(9):315-9. PubMed ID: 4543377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.